Kolon to work with Topimed on anti-skin atrophy drug

Published: 2009-05-06 06:56:00

Updated: 2009-05-06 06:56:00

Kolon Pharm said that it has agreed with Israel based Topimed LTD, a biopharmaceutical company, to work together in the development of a skin anti-ageing preparation.

Kolon said that it signed a memorandum of understanding with Topimed and Korea-Israel Industrial R&D Foundation (KORIL-RDF) on ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK